Wuhan Hamilton Biotechnology Co., Ltd.
Wuhan Hamilton Biotechnology Co., Ltd.
Explore linked clinical trials.3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Human Umbilical Cord Mesenchymal Stem Cell Injection for Diabetic Nephropathy | Diabetes Complications, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, diabetes mellitus, diabetic kidney disease, endocrine system disorder, kidney disorder, urinary system disorder | Recruiting | Phase 1 | 2026-09-16 | NCT07822152 | |
| Stem Cell Therapy for Intracerebral Hemorrhage | Hemorrhage, Inflammation, Intracranial Hemorrhages, Pathologic Processes, Pathological Conditions, Signs and Symptoms, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, intracerebral hemorrhage, nervous system disorder, vascular disorder | Not yet recruiting | Phase 1 / Phase 2 | 2025-03-06 | NCT06862388 | |
| Phase I Clinical Trial of UC-MSCs in the Treatment of Knee Osteoarthritis | arthritic joint disease, arthropathy, musculoskeletal system disorder, osteoarthritis, osteoarthritis, knee, rheumatic disorder | Recruiting | Phase 1 | 2024-07-01 | NCT06463847 |